Basics Tandem Diabetes Care, Inc. Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application. IPO Date: December 1, 2013 Sector: Healthcare Industry: Medical Devices Market Cap: $850.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.96 | 2.77% Avg Daily Range (30 D): $0.36 | 2.87% Avg Daily Range (90 D): $0.46 | 2.74% Institutional Daily Volume Avg Daily Volume: .93M Avg Daily Volume (30 D): 2.12M Avg Daily Volume (90 D): 1.61M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 67 Institutional Trades Total Inst.Trades: 6,627 Avg Inst. Trade: $2.77M Avg Inst. Trade (30 D): $2.31M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.92M Avg Closing Trade (30 D): $3.38M Avg Closing Trade (90 D): $3.83M Avg Closing Volume: 102.65K     News Aug 7, 2025 @ 5:50 PM Insulet Peer Tandem Diabetes Underwhelming Earning... Source: Vandana Singh Jan 24, 2025 @ 10:00 AM Infusion Devices Market to Reach US$ 23.08 Billion... Source: The Insight Partners Dec 24, 2024 @ 2:30 PM Insulin Pump Market Valuation to Jump to Reach US$... Source: Astute Analytica Sep 19, 2024 @ 10:49 PM Why Tandem Diabetes Care Stock Thrashed the Market... Source: Eric Volkman Jul 23, 2024 @ 5:31 PM [Latest] US Diabetes Devices Market Size/Share Wor... Source: Custom Market Insights Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.08 $-.78 $-1.97 Diluted EPS $-3.08 $-.78 $-1.97 Revenue $ 1B $ 240.68M $ 234.42M Gross Profit $ 526.37M $ 125.86M $ 118.41M Net Income / Loss $ -205.45M $ -52.4M $ -130.56M Operating Income / Loss $ -199.36M $ -51.81M $ -120.88M Cost of Revenue $ 475.35M $ 114.82M $ 116.02M Net Cash Flow $ 16.42M $ 10.54M $ -15.66M PE Ratio     Splits Oct 10, 2017:   1:10